M Gemenetzi1, A J Lotery. 1. Southampton Eye Unit, Southampton General Hospital, Southampton, UK.
Abstract
PURPOSE: To investigate phenotypic variability in terms of best-corrected visual acuity (BCVA) in patients with Stargardt disease (STGD) and confirmed ABCA4 mutations. METHODS: Entire coding region analysis of the ABCA4 gene by direct sequencing of seven patients with clinical findings of STGD seen in the Retina Clinics of Southampton Eye Unit between 2002 and 2011.Phenotypic variables recorded were BCVA, fluorescein angiographic appearance, electrophysiology, and visual fields. RESULTS: All patients had heterozygous amino acid-changing variants (missense mutations) in the ABCA4 gene. A splice sequence change was found in a 30-year-old patient with severly affected vision. Two novel sequence changes were identified: a missense mutation in a mildly affected 44-year-old patient and a frameshift mutation in a severly affected 34-year-old patient. CONCLUSION: The identified ABCA4 mutations were compatible with the resulting phenotypes in terms of BCVA. Higher BCVAs were recorded in patients with missense mutations. Sequence changes, predicted to have more deleterious effect on protein function, resulted in a more severe phenotype. This case series of STGD patients demonstrates novel genotype/phenotype correlations, which may be useful to counselling of patients. This information may prove useful in selection of candidates for clinical trials in ABCA4 disease.
PURPOSE: To investigate phenotypic variability in terms of best-corrected visual acuity (BCVA) in patients with Stargardt disease (STGD) and confirmed ABCA4 mutations. METHODS: Entire coding region analysis of the ABCA4 gene by direct sequencing of seven patients with clinical findings of STGD seen in the Retina Clinics of Southampton Eye Unit between 2002 and 2011.Phenotypic variables recorded were BCVA, fluorescein angiographic appearance, electrophysiology, and visual fields. RESULTS: All patients had heterozygous amino acid-changing variants (missense mutations) in the ABCA4 gene. A splice sequence change was found in a 30-year-old patient with severly affected vision. Two novel sequence changes were identified: a missense mutation in a mildly affected 44-year-old patient and a frameshift mutation in a severly affected 34-year-old patient. CONCLUSION: The identified ABCA4 mutations were compatible with the resulting phenotypes in terms of BCVA. Higher BCVAs were recorded in patients with missense mutations. Sequence changes, predicted to have more deleterious effect on protein function, resulted in a more severe phenotype. This case series of STGDpatients demonstrates novel genotype/phenotype correlations, which may be useful to counselling of patients. This information may prove useful in selection of candidates for clinical trials in ABCA4 disease.
Authors: A R Webster; E Héon; A J Lotery; K Vandenburgh; T L Casavant; K T Oh; G Beck; G A Fishman; B L Lam; A Levin; J R Heckenlively; S G Jacobson; R G Weleber; V C Sheffield; E M Stone Journal: Invest Ophthalmol Vis Sci Date: 2001-05 Impact factor: 4.799
Authors: B Jeroen Klevering; August F Deutman; Alessandra Maugeri; Frans P M Cremers; Carel B Hoyng Journal: Graefes Arch Clin Exp Ophthalmol Date: 2004-12-22 Impact factor: 3.117
Authors: Jana Zernant; Carl Schubert; Kate M Im; Tomas Burke; Carolyn M Brown; Gerald A Fishman; Stephen H Tsang; Peter Gouras; Michael Dean; Rando Allikmets Journal: Invest Ophthalmol Vis Sci Date: 2011-10-31 Impact factor: 4.799
Authors: A Maugeri; M A van Driel; D J van de Pol; B J Klevering; F J van Haren; N Tijmes; A A Bergen; K Rohrschneider; A Blankenagel; A J Pinckers; N Dahl; H G Brunner; A F Deutman; C B Hoyng; F P Cremers Journal: Am J Hum Genet Date: 1999-04 Impact factor: 11.025
Authors: R Allikmets; N Singh; H Sun; N F Shroyer; A Hutchinson; A Chidambaram; B Gerrard; L Baird; D Stauffer; A Peiffer; A Rattner; P Smallwood; Y Li; K L Anderson; R A Lewis; J Nathans; M Leppert; M Dean; J R Lupski Journal: Nat Genet Date: 1997-03 Impact factor: 38.330
Authors: K Jaakson; J Zernant; M Külm; A Hutchinson; N Tonisson; D Glavac; M Ravnik-Glavac; M Hawlina; M R Meltzer; R C Caruso; F Testa; A Maugeri; C B Hoyng; P Gouras; F Simonelli; R A Lewis; J R Lupski; F P M Cremers; R Allikmets Journal: Hum Mutat Date: 2003-11 Impact factor: 4.878
Authors: R A Lewis; N F Shroyer; N Singh; R Allikmets; A Hutchinson; Y Li; J R Lupski; M Leppert; M Dean Journal: Am J Hum Genet Date: 1999-02 Impact factor: 11.025
Authors: Maria A Parker; Laura R Erker; Isabelle Audo; Dongseok Choi; Saddek Mohand-Said; Kastytis Sestakauskas; Patrick Benoit; Terence Appelqvist; Melissa Krahmer; Caroline Ségaut-Prévost; Brandon J Lujan; Ambar Faridi; Elvira N Chegarnov; Peter N Steinkamp; Cristy Ku; Mariana Matioli da Palma; Pierre-Olivier Barale; Sarah Ayelo-Scheer; Andreas Lauer; Tim Stout; David J Wilson; Richard G Weleber; Mark E Pennesi; José Alain Sahel; Paul Yang Journal: Am J Ophthalmol Date: 2022-03-04 Impact factor: 5.488